Vantage Hemp Co. Adopts C15 Solutions’ eQMS
March 23, 2023OVERVIEW OF THE MARKET The global cannabidiol (CBD) market was valued at 4.9 billion USD in 2021 and is projected to attain a value of 47.22 billion USD by 2028 at a compound annual growth rate (CAGR) of 21.3% during...
Vantage Hemp Co. Looks Ahead to 2023 After a Breakout Year in International Markets and New Industries
December 14, 2022Industry leader is now setting the bar beyond CBD (cannabidiol) with pharmaceutical-grade production and manufacturing for a variety of plant-based products Vantage Hemp Co. (“Vantage” or the “Company”), has continued to stand out in an ever-changing CBD industry through an...
Vantage Hemp Co. Establishes Softgel Production for White Label Partners and Beyond
August 11, 2022Pharmaceutical-grade CBD producer shows commitment to increasing white label format capabilities Industry leader, Vantage Hemp Co. (“Vantage” or the “Company”), announces softgel capabilities in response to meeting client and consumer demands. As the Company expands its white label and contract manufacturing services,...
Vantage Hemp Co. Submits a Drug Master File for CBD Distillate to the U.S. Food & Drug Administration
April 28, 2022Vantage Hemp Co. further solidifies its position as an industry leader by its announcement of a DMF submission for its CBD distillate to the FDA.
Vantage Hemp Co. Launches Bulk Formulation Services
March 28, 2022Vantage Hemp is a highly accredited CBD extractor - one of North America’s leading hemp processors with both ICH Q7 and WHO GMP certified facilities.
World Leading Contract Manufacturing, White Label and Formulations
January 26, 2022Vantage delivers world leading contract manufacturing, white label, and formulation services to WHO GMP and ICH Q7 standards..
Vantage Hemp Co. is in the Final Stages of its DMF Submissions
January 26, 2022As an active pharmaceutical ingredient (API) manufacturer, Vantage prepares for its DMF submissions to the FDA to support the quality and safety of its products.
